Lisa Prosser

 Lisa Prosser, PhD, MS
Marilyn Fisher Blanch Research Professor of Pediatrics
Associate Vice President for Research-Health Sciences and Research Faculty Affairs, Office of the Vice President for Research
Professor of Pediatrics, Medical School
Professor of Health Management and Policy, School of Public Health
[email protected]
Available to mentor
Lisa Prosser
Lisa Prosser, PhD, MS
Professor
  • Center Memberships
  • Recent Publications

  • Manage Your Profile

    • Center Memberships
    • Center Member
      Opioid Research Institute
    • Center Member
      Caswell Diabetes Institute
    • Center Member
      Institute for Healthcare Policy and Innovation

    Recent Publications

     See All Publications
    • Journal Article
      EE198 DEVELOPING DIRECT EQUITY WEIGHTS FOR COST-EFFECTIVENESS ANALYSIS: RESULTS FROM A US-BASED DISCRETE CHOICE EXPERIMENT
      Cadham C, Ali S, Meza R, Prosser L. Value in Health, 2026 Jun 28; 29 (6): s100 DOI:10.1016/j.jval.2026.03.493
    • Journal Article
      EE274 ASSESSING THE VALUE OF LOST SCHOOLING DUE TO ILLNESS AMONG CHILDREN IN THE UNITED STATES
      Darwar R, Shah D, Rose A, Prosser L. Value in Health, 2026 Jun 28; 29 (6): s115 DOI:10.1016/j.jval.2026.03.568
    • Journal Article
      When Cost-Effectiveness Crosses Borders-Nirsevimab as an Example.
      Prosser LA, Hutton DW. JAMA Pediatr, 2026 Apr 13; DOI:10.1001/jamapediatrics.2026.0823
      PMID: 41973441
    • Journal Article
      Valuing Child and Adolescent Health States to Derive Utilities for Use in Economic Evaluation: A Good Practices Report of an ISPOR Task Force
      Matza LS, Rowen D, Chandler F, Dalziel K, Ghabri S, Law EH, Prosser LA, Rivero-Arias O, Shah K, Stolk E, Wolff J, Devlin N. Value in Health, 2026 Apr 1; 29 (4): 535 - 546. DOI:10.1016/j.jval.2025.12.016
      PMID: 41581858
    • Journal Article
      Cost-Effectiveness of Universal Newborn Screening and Disease-Modifying Therapies for Spinal Muscular Atrophy in Taiwan
      Chiang WL, Jong YJ, Prosser LA, Chen HF, Chen CY, Hsieh HM. Value in Health Regional Issues, 2026 Jan 1; DOI:10.1016/j.vhri.2026.101654
    • Preprint
      Estimating Impact of SARS-CoV-2 Infection on Health-Related Quality of Life among Persons Aged 8 years and Older, August 2020-July 2022
      Johnson S, Nguyen HQ, Stockwell MS, Porucznik CA, Karron RA, Dawood FS, Prosser LA, Sarakki AP, Stanford JB, Hetrich M, Schappell E, Knoll MD, Veguilla V, Mellis A, Duque J, Jeddy Z, Pike J, Rolfes MA. 2025 Dec 13; medRxiv, DOI:10.64898/2025.12.10.25341971
    • Journal Article
      Out-of-pocket costs, time burden, and caregiver quality of life associated with pediatric medically attended respiratory syncytial virus illnesses.
      Rose AM, Mercon KR, Gebremariam A, Pike J, Prosser LA. Cost Eff Resour Alloc, 2025 Aug 12; 23 (1): 42 DOI:10.1186/s12962-025-00646-4
      PMID: PMC12344828
    • Journal Article
      Cost-Effectiveness of 2023-2024 COVID-19 Vaccination in US Adults.
      Prosser LA, Wallace M, Rose AM, Mercon K, Janusz CB, Gebremariam A, Hutton DW, Leidner AJ, Zhou F, Ortega-Sanchez IR, Moulia D, Link-Gelles R, Saydah S, Shah M, Pike J. JAMA Netw Open, 2025 Aug 1; 8 (8): e2523688 DOI:10.1001/jamanetworkopen.2025.23688
      PMID: PMC12332627

    Featured News & Stories

         vials over money
    Health Lab

    Broad COVID-19 vaccination makes economic sense, especially for older adults

    COVID-19 vaccination of people over 65 would save the country money, and vaccination of younger groups of adults would be a reasonable investment 
         water droplet with money in it
    Health Lab

    Investing in COVID-19 vaccination more than paid off for U.S.

    The money spent to develop, test, buy and administer the first COVID-19 vaccine was more than made up for by prevented medical care and lost productivity.